Actively Recruiting
Feasibility/Acceptability of Attentional-Control Training in Survivors
Led by Children's National Research Institute · Updated on 2025-01-10
50
Participants Needed
1
Research Sites
115 weeks
Total Duration
On this page
Sponsors
C
Children's National Research Institute
Lead Sponsor
S
St. Jude Children's Research Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a multicenter pilot randomized controlled trial, with an active control condition, of the feasibility, acceptability, and preliminary efficacy of EndeavorRx in a cohort of survivors of acute lymphoblastic leukemia or brain tumor ages 8-16 who are \> 1 year from the end of therapy.
CONDITIONS
Official Title
Feasibility/Acceptability of Attentional-Control Training in Survivors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 8-16 years at time of screening.
- History of diagnosis of acute lymphoblastic leukemia (ALL) or brain tumor (BT).
- At least 1 year from completion of planned therapy and stable from a disease standpoint.
- Participating child and caregiver are fluent in spoken English.
- Availability of a caregiver who is willing and capable of providing support and supervision during cognitive training.
- Participating child is either not taking any prescribed stimulant medication for attention difficulties or has been prescribed a stable dose of stimulant medication for at least 30 days prior to enrollment.
- Only patients with a T-score 6 75th percentile on the CPT-3 Omission Errors scale or on the BRIEF-2 Cognitive Regulation Index will be randomized.
You will not qualify if you...
- History of photosensitive seizures.
- Motor, visual, or auditory handicap that prevents computer use.
- Mental health condition that precludes, or takes treatment precedence over, participation in cognitive training.
- Full-scale IQ less than 80 as estimated by WASI-II (Vocabulary and Matrix Reasoning) at baseline assessment.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Children's National Hospital
Washington D.C., District of Columbia, United States, 20010
Actively Recruiting
Research Team
S
Steven Hardy, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here